Glenn Sabin, founder of FON, is a nationally recognized thought leader who positions health innovators, enterprises, and organizations for sustainable growth. Drawing on deep experience in media, strategy, marketing, and business development—and his own compelling n-of-1 cancer journey—he champions personalized medicine and the creation of real-world data and evidence to help define a new, accessible standard of care.
Glenn is a 25-year cancer “thriver” who created a comprehensive, integrative oncology approach to achieve a complete pathological remission of his CLL (chronic lymphocytic leukemia)—considered an “incurable” disease—without conventional intervention. Glenn’s case, part of the medical literature, has been chronicled through the Harvard medical system and his personal oncologist, Lee M. Nadler, MD, Dean of Clinical and Translational Research at Harvard Medical School.
After a long career running an award-winning media and content marketing company, Glenn sold his firm in 2009 to follow his passion for truly personalized approaches to healing, and to explore emerging opportunities within the dynamic, growing industry.
Glenn launched FON Consulting in 2010 and has advised hundreds of organizations across the country and globally on business development and strategy.
Glenn is currently a faculty member at Duke University’s Leadership Program in Health and Well-Being, where he presents a course on Health and Well-being Thought Leadership.
Twenty-five years ago my doctors had no cure for my cancer. So I went on a quest to find my own treatment. This is my story.
